MK
Mohammed Kutty Cholakkal
About Mohammed Kutty Cholakkal
Data last updated:
Mohammed Kutty Cholakkal is a Partner at Dosage Hyper Pharma Llp (since 2023) and Director at Safa Institute Of Health Sciences Private Limited (since 2022). The companies operate in Pharma, Non-Profit Organizations and Metals and Minerals. Earlier, Mohammed Kutty Cholakkal was a Director at Khayar Enterprises Limited (2016–2017) and Director at Orchid Institute Of Healthcare And Research Private Limited (2017–2018).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Partner | 10 May 2023 | 2018 | Active | ||
| Director | 28 Mar 2022 | 2022 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 28 Dec 2016 | 2016 | Strike Off | ||
| Director | 19 Aug 2017 | 1996 | ₹11.29 Cr (FY 2023) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Mohammed Kutty Cholakkal
| Name | DIN | Company | Designation |
|---|---|---|---|
| Faizal Babu Ambalancheeri | 09444920 | Dosage Hyper Pharma Llp | Designated Partner |
| Mohammed | 08187849 | Dosage Hyper Pharma Llp | Designated Partner |
| Mohammed Kalangadan | 06996253 | Safa Institute Of Health Sciences Private Limited | Managing Director |
| Sulthanali Chakkumkuth | 07810156 | Safa Institute Of Health Sciences Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Mohammed Kutty Cholakkal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mohammed Kutty Cholakkal
Mohammed Kutty Cholakkal currently holds 2 directorships: Dosage Hyper Pharma Llp (Partner, since 10 May 2023); Safa Institute Of Health Sciences Private Limited (Director, since 28 Mar 2022).
Mohammed Kutty Cholakkal was first appointed on 28 Dec 2016 as Director at Khayar Enterprises Limited. The most recent appointment on record is 10 May 2023 at Dosage Hyper Pharma Llp.
Mohammed Kutty Cholakkal held 2 earlier board appointments: Khayar Enterprises Limited (Director, 28 Dec 2016 to 20 May 2017); Orchid Institute Of Healthcare And Research Private Limited (Director, 19 Aug 2017 to 29 Mar 2018).
The current boards of Mohammed Kutty Cholakkal's companies include Faizal Babu Ambalancheeri (Dosage Hyper Pharma Llp), Mohammed (Dosage Hyper Pharma Llp), Mohammed Kalangadan (Safa Institute Of Health Sciences Private Limited), Sulthanali Chakkumkuth (Safa Institute Of Health Sciences Private Limited).